Charles M. Ewing

9.5k total citations
61 papers, 4.7k citations indexed

About

Charles M. Ewing is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Charles M. Ewing has authored 61 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 28 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Charles M. Ewing's work include Prostate Cancer Treatment and Research (24 papers), Cancer-related gene regulation (17 papers) and Wnt/β-catenin signaling in development and cancer (13 papers). Charles M. Ewing is often cited by papers focused on Prostate Cancer Treatment and Research (24 papers), Cancer-related gene regulation (17 papers) and Wnt/β-catenin signaling in development and cancer (13 papers). Charles M. Ewing collaborates with scholars based in United States, Germany and Netherlands. Charles M. Ewing's co-authors include William B. Isaacs, Jun Luo, Bob S. Carter, Jurga Sauvageot, Ronald A. Morton, William B. Isaacs, Jeffrey M. Trent, G. Steven Bova, Angelo M. De Marzo and Yidong Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Cancer.

In The Last Decade

Charles M. Ewing

61 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles M. Ewing United States 36 2.8k 1.9k 1.2k 920 669 61 4.7k
Tarek A. Bismar Canada 37 2.4k 0.9× 2.6k 1.3× 1.3k 1.1× 1.1k 1.2× 558 0.8× 129 4.8k
Cathy D. Vocke United States 35 2.9k 1.0× 2.2k 1.1× 1.2k 1.0× 464 0.5× 636 1.0× 79 4.2k
Jonathan M. Kurie United States 45 3.2k 1.2× 1.2k 0.6× 998 0.9× 1.9k 2.1× 724 1.1× 101 5.3k
Bharathi Laxman United States 28 4.5k 1.6× 2.4k 1.2× 2.6k 2.3× 769 0.8× 441 0.7× 38 6.4k
Arvind K. Virmani United States 32 3.4k 1.2× 844 0.4× 1.0k 0.9× 1.4k 1.5× 738 1.1× 43 4.8k
Brian C. Lewis United States 33 3.2k 1.1× 668 0.3× 1.3k 1.1× 1.2k 1.3× 518 0.8× 53 4.4k
Wennuan Liu United States 31 1.7k 0.6× 1.6k 0.9× 1.1k 1.0× 502 0.5× 482 0.7× 54 3.1k
Pernilla Wikström Sweden 38 2.3k 0.8× 1.9k 1.0× 1.3k 1.1× 1.1k 1.2× 374 0.6× 105 4.5k
Frank Hilberg Austria 28 2.0k 0.7× 1.2k 0.6× 497 0.4× 1.1k 1.2× 355 0.5× 57 4.0k
Anthony E. Reeve New Zealand 38 3.9k 1.4× 962 0.5× 634 0.6× 747 0.8× 1.5k 2.2× 90 5.4k

Countries citing papers authored by Charles M. Ewing

Since Specialization
Citations

This map shows the geographic impact of Charles M. Ewing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles M. Ewing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles M. Ewing more than expected).

Fields of papers citing papers by Charles M. Ewing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles M. Ewing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles M. Ewing. The network helps show where Charles M. Ewing may publish in the future.

Co-authorship network of co-authors of Charles M. Ewing

This figure shows the co-authorship network connecting the top 25 collaborators of Charles M. Ewing. A scholar is included among the top collaborators of Charles M. Ewing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles M. Ewing. Charles M. Ewing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Michelle L., et al.. (2011). Prostate cancer‐derived angiogenin stimulates the invasion of prostate fibroblasts. Journal of Cellular and Molecular Medicine. 16(1). 193–201. 13 indexed citations
2.
Fujita, Kazutoshi, Charles M. Ewing, David Y. Chan, et al.. (2008). Endoglin (CD105) as a urinary and serum marker of prostate cancer. International Journal of Cancer. 124(3). 664–669. 49 indexed citations
3.
Fujita, Kazutoshi, Charles M. Ewing, Lori J. Sokoll, et al.. (2008). Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation. The Prostate. 68(8). 872–882. 39 indexed citations
4.
Liu, Wennuan, Charles M. Ewing, Bao‐Li Chang, et al.. (2007). Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers. Genes Chromosomes and Cancer. 46(11). 972–980. 36 indexed citations
5.
Gu, Yongpeng, Hongzhen Li, Jun Miki, et al.. (2006). Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines. Experimental Cell Research. 312(6). 831–843. 67 indexed citations
6.
Dunn, Thomas A., Shenglin Chen, Dennis Faith, et al.. (2006). A Novel Role of Myosin VI in Human Prostate Cancer. American Journal Of Pathology. 169(5). 1843–1854. 112 indexed citations
7.
Xu, Jianfeng, S. Lilly Zheng, Akira Komiya, et al.. (2003). Common Sequence Variants of the Macrophage Scavenger Receptor 1 Gene Are Associated with Prostate Cancer Risk. The American Journal of Human Genetics. 72(1). 208–212. 68 indexed citations
8.
Luo, Jun, Thomas A. Dunn, Charles M. Ewing, et al.. (2002). Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis. The Prostate. 51(3). 189–200. 109 indexed citations
9.
Zheng, Siqun L., John D. Carpten, Nina N. Nupponen, et al.. (2001). Evaluation of Linkage and Association of HPC2/ELAC2 in Patients with Familial or Sporadic Prostate Cancer. The American Journal of Human Genetics. 68(4). 901–911. 82 indexed citations
10.
Xu, Jianfeng, Siqun L. Zheng, Bao-Li Chang, et al.. (2001). Linkage of prostate cancer susceptibility loci to chromosome 1. Human Genetics. 108(4). 335–345. 67 indexed citations
11.
Ewing, Charles M., et al.. (2000). Detection and analysis of ?-catenin mutations in prostate cancer. The Prostate. 45(4). 323–334. 148 indexed citations
12.
Linkels, Marianne, Marion J.G. Bussemakers, Friedel Nollet, et al.. (1997). Molecular Cloning of an Alternative Human αE-Catenin cDNA. Biochemical and Biophysical Research Communications. 237(1). 177–181. 2 indexed citations
13.
Paul, R., Charles M. Ewing, David F. Jarrard, & William B. Isaacs. (1997). The cadherin cell—cell adhesion pathway in prostate cancer progression. British Journal of Urology. 79(S1). 37–43. 80 indexed citations
14.
Bell, Ford W., Jeffrey S. Klausner, David W. Hayden, et al.. (1995). Evaluation of Serum and Seminal Plasma Markers in the Diagnosis of Canine Prostatic Disorders. Journal of Veterinary Internal Medicine. 9(3). 149–153. 63 indexed citations
15.
Isaacs, William B., G. Steven Bova, Ronald A. Morton, et al.. (1994). Genetic Alterations in Prostate Cancer. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 653–659. 44 indexed citations
16.
Moody, D. Branch, John C. Robinson, Charles M. Ewing, Audrey J. Lazenby, & William B. Isaacs. (1994). Interleukin‐2 transfected prostate cancer cells generate a local antitumor effect in vivo. The Prostate. 24(5). 244–251. 36 indexed citations
17.
Morton, Ronald A., Charles M. Ewing, Akira Nagafuchi, Sachiko Tsukita, & William B. Isaacs. (1993). Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.. PubMed. 53(15). 3585–90. 250 indexed citations
18.
Biswas, Esther E., Charles M. Ewing, & Subhasis B. Biswas. (1993). Characterization of the DNA-dependent ATPase and a DNA unwinding activity associated with the yeast DNA polymerase .alpha. complex. Biochemistry. 32(12). 3020–3026. 8 indexed citations
19.
Smith, Carolyn L., Charles M. Ewing, Mark T. Mellon, Robert Shorr, & Tikam C. Jain. (1989). HydroLinkTM gel electrophoresis (HLGE). III. High DNA loading capacity and recovery of dsDNA. Journal of Biochemical and Biophysical Methods. 19(1). 65–73. 11 indexed citations
20.
Smith, Carolyn L., et al.. (1989). HydroLinkTM gel electrophoresis (HLGE). II. Applications of a new polymer matrix to dsDNA analysis. Journal of Biochemical and Biophysical Methods. 19(1). 51–64. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tarek A. Bismar Breakdown of academic impact, for papers by Cathy D. Vocke Breakdown of academic impact, for papers by Jonathan M. Kurie Breakdown of academic impact, for papers by Bharathi Laxman Breakdown of academic impact, for papers by Arvind K. Virmani Breakdown of academic impact, for papers by Brian C. Lewis Breakdown of academic impact, for papers by Wennuan Liu Breakdown of academic impact, for papers by Pernilla Wikström Breakdown of academic impact, for papers by Frank Hilberg Breakdown of academic impact, for papers by Anthony E. Reeve
Rankless by CCL
2026